Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 29, 2026 08:00 ET | Source: Noom Inc

Noom Health partners with Levrx to bring personalized weight management support into the pharmacy benefits experience

Noom Health is partnering with Levrx to optimize metabolic health/ GLP-1 programs directly through existing pharmacy benefit platforms
July 23, 2026 13:24 ET | Source: The Akkermansia Company

Recent Patent and Court Developments in the U.S. and Europe Reinforce Danone’s Patent Position as Global Commercialization of Akkermansia MucT® Expands

Danone subsidiary The Akkermansia Company announced recent patent and legal developments supporting global commercialization of Akkermansia MucT®.
July 23, 2026 13:10 ET | Source: Serotonin

Serotonin Centers Expands into Greater San Diego with New Del Mar Location

Serotonin Centers opens in Del Mar, bringing physician-led hormone optimization, medical weight loss & recovery to greater San Diego.
July 15, 2026 11:51 ET | Source: Novo Nordisk A/S

Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved

EU approves Novo Nordisk's Wegovy® pill as first oral GLP-1 for weight management; as well as ready-to-use pen for Wegovy 7.2 mg injection
July 10, 2026 07:30 ET | Source: PMGC Holdings Inc.

NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression

NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression
July 07, 2026 07:35 ET | Source: Vivani Medical, Inc.

Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

Vivani Medical entered into agreement with Novo Nordisk to evaluate its miniature subdermal semaglutide (GLP-1) implant for weight management
July 01, 2026 07:30 ET | Source: PMGC Holdings Inc.

NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva Biosciences

NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva Biosciences
June 29, 2026 05:00 ET | Source: Resalis Therapeutics SRL

Resalis Announces Initiation of Phase 1b Clinical Study Evaluating RES-010 as Treatment to Address Unmet Needs in Obesity

Torino, Italy, June 29, 2026 – Resalis Therapeutics today announced the dosing of the first participant in a Phase 1b clinical study of its lead candidate, RES-010, a novel antisense oligonucleotide...
June 21, 2026 07:33 ET | Source: TheDoseReport

TheDoseReport Announces Which GLP-1 is Best? Semaglutide and Tirzepatide

NEW YORK, June 21, 2026 (GLOBE NEWSWIRE) -- TheDoseReport.com Releases Analysis: Which GLP-1 is Best? Semaglutide and Tirzepatide Compared. Confused about GLP-1 options for weight management? Take...
June 16, 2026 16:04 ET | Source: TheDoseReport

TheDoseReport Announces Medvi Review - Telehealth GLP-1 Programs

NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- TheDoseReport.com announces the release of its comprehensive Medvi Review, focusing on telehealth GLP-1 programs for weight management. Considering GLP-1...